Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity.
Journal Information
Full Title: Br J Clin Pharmacol
Abbreviation: Br J Clin Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"COMPETING INTERESTS S.A., M.H., C.K. and R.J.‐L. are AstraZeneca employees and own shares in AstraZeneca, while C.W. and T.B.A. are former AstraZeneca employees. K.E.K., I.R., E.S., H.C., V.K., M.K.K., M.H.H., J.K.H., L.K.J., R.S., P.A., J.H. and A.Å. have no conflict of interest to declare."
Funding Disclosure
Evidence found in paper:
"Funding information Swedish Research Council, Grant/Award Numbers: 01951, 5715; AstraZeneca, Sweden; Department of Pharmacy, University of Oslo, Norway; Vestfold Hospital Trust, Norway"
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025